Govt permits 6 companies to produce Covid-19 drug remdesivir
The six pharmaceutical companies that got the permission are -- Beximco, Beacon, Eskayef (SK-F), Incepta, Square and Healthcare
The Directorate General of Drug Administration has given permission to six pharmaceutical companies to produce the potential Covid-19 drug "remdesivir".
The companies are -- Beximco, Beacon, Eskayef (SK-F), Incepta, Square and Healthcare.
The Drug Administration gave permission considering the current coronavirus situation in the country, Assistant Director Mohammad Salahuddin told The Business Standard.
Keep updated, follow The Business Standard's Google news channel
A drug administration official, unwilling to be named, said that SK-F and Beximco are going to start the production after importing the raw materials within this month.
But the decision on - when the medicines will be sent to the hospitals - is yet to be made. The decision will come after the trial of the medicine.
Remdesivir is being used on Covid-19 patients in several countries including the US. It has a history to work well against the SARS and Ebola virus.
